247 related articles for article (PubMed ID: 29339107)
1. Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeutics.
Zhou Z; Liu T; Zhang J; Zhan P; Liu X
Drug Discov Today; 2018 Mar; 23(3):503-518. PubMed ID: 29339107
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface.
Yuan S; Chu H; Ye J; Singh K; Ye Z; Zhao H; Kao RY; Chow BK; Zhou J; Zheng BJ
Antiviral Res; 2017 Jan; 137():58-66. PubMed ID: 27840201
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus.
He X; Zhou J; Bartlam M; Zhang R; Ma J; Lou Z; Li X; Li J; Joachimiak A; Zeng Z; Ge R; Rao Z; Liu Y
Nature; 2008 Aug; 454(7208):1123-6. PubMed ID: 18615018
[TBL] [Abstract][Full Text] [Related]
4. Focusing on the Influenza Virus Polymerase Complex: Recent Progress in Drug Discovery and Assay Development.
Zhang J; Hu Y; Musharrafieh R; Yin H; Wang J
Curr Med Chem; 2019; 26(13):2243-2263. PubMed ID: 29984646
[TBL] [Abstract][Full Text] [Related]
5. Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-Protein Interaction as a Target for Next-Generation Anti-influenza Therapeutics.
Massari S; Goracci L; Desantis J; Tabarrini O
J Med Chem; 2016 Sep; 59(17):7699-718. PubMed ID: 27046062
[TBL] [Abstract][Full Text] [Related]
6. Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction.
Watanabe K; Ishikawa T; Otaki H; Mizuta S; Hamada T; Nakagaki T; Ishibashi D; Urata S; Yasuda J; Tanaka Y; Nishida N
Sci Rep; 2017 Aug; 7(1):9500. PubMed ID: 28842649
[TBL] [Abstract][Full Text] [Related]
7. Screening for Novel Small-Molecule Inhibitors Targeting the Assembly of Influenza Virus Polymerase Complex by a Bimolecular Luminescence Complementation-Based Reporter System.
Li C; Wang Z; Cao Y; Wang L; Ji J; Chen Z; Deng T; Jiang T; Cheng G; Qin FX
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031371
[TBL] [Abstract][Full Text] [Related]
8. Hsp90 inhibitors reduce influenza virus replication in cell culture.
Chase G; Deng T; Fodor E; Leung BW; Mayer D; Schwemmle M; Brownlee G
Virology; 2008 Aug; 377(2):431-9. PubMed ID: 18570972
[TBL] [Abstract][Full Text] [Related]
9. [Structural and Biochemical Analyses on the RNA-dependent RNA Polymerase of Influenza Virus for Development of Novel Anti-influenza Agents].
Hatakeyama D
Yakugaku Zasshi; 2017; 137(2):205-214. PubMed ID: 28154333
[TBL] [Abstract][Full Text] [Related]
10. The Short Form of the Zinc Finger Antiviral Protein Inhibits Influenza A Virus Protein Expression and Is Antagonized by the Virus-Encoded NS1.
Tang Q; Wang X; Gao G
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807230
[TBL] [Abstract][Full Text] [Related]
11. Influenza virus polymerase subunits co-evolve to ensure proper levels of dimerization of the heterotrimer.
Chen KY; Santos Afonso ED; Enouf V; Isel C; Naffakh N
PLoS Pathog; 2019 Oct; 15(10):e1008034. PubMed ID: 31581279
[TBL] [Abstract][Full Text] [Related]
12. A Parallel Phenotypic Versus Target-Based Screening Strategy for RNA-Dependent RNA Polymerase Inhibitors of the Influenza A Virus.
Zhao X; Wang Y; Cui Q; Li P; Wang L; Chen Z; Rong L; Du R
Viruses; 2019 Sep; 11(9):. PubMed ID: 31491939
[TBL] [Abstract][Full Text] [Related]
13. Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.
Giannecchini S; Wise HM; Digard P; Clausi V; Del Poggetto E; Vesco L; Puzelli S; Donatelli I; Azzi A
Antiviral Res; 2011 Oct; 92(1):64-72. PubMed ID: 21741410
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel compound with antiviral activity against influenza A virus depending on PA subunit of viral RNA polymerase.
Yamada K; Koyama H; Hagiwara K; Ueda A; Sasaki Y; Kanesashi SN; Ueno R; Nakamura HK; Kuwata K; Shimizu K; Suzuki M; Aida Y
Microbes Infect; 2012 Aug; 14(9):740-7. PubMed ID: 22441116
[TBL] [Abstract][Full Text] [Related]
15. Temperature-Sensitive Mutants in the Influenza A Virus RNA Polymerase: Alterations in the PA Linker Reduce Nuclear Targeting of the PB1-PA Dimer and Result in Viral Attenuation.
Da Costa B; Sausset A; Munier S; Ghounaris A; Naffakh N; Le Goffic R; Delmas B
J Virol; 2015 Jun; 89(12):6376-90. PubMed ID: 25855727
[TBL] [Abstract][Full Text] [Related]
16. Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance.
Nannetti G; Massari S; Mercorelli B; Bertagnin C; Desantis J; Palù G; Tabarrini O; Loregian A
Antiviral Res; 2019 May; 165():55-64. PubMed ID: 30885750
[TBL] [Abstract][Full Text] [Related]
17. Functional domains of the influenza A virus PB2 protein: identification of NP- and PB1-binding sites.
Poole E; Elton D; Medcalf L; Digard P
Virology; 2004 Mar; 321(1):120-33. PubMed ID: 15033571
[TBL] [Abstract][Full Text] [Related]
18. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.
Yuan S; Chu H; Zhao H; Zhang K; Singh K; Chow BK; Kao RY; Zhou J; Zheng BJ
Antiviral Res; 2016 Jan; 125():34-42. PubMed ID: 26593979
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization of recombinant IAV polymerase reveals a stable complex between viral PA-PB1 heterodimer and host RanBP5.
Swale C; Monod A; Tengo L; Labaronne A; Garzoni F; Bourhis JM; Cusack S; Schoehn G; Berger I; Ruigrok RW; Crépin T
Sci Rep; 2016 Apr; 6():24727. PubMed ID: 27095520
[TBL] [Abstract][Full Text] [Related]
20. Structural basis of an essential interaction between influenza polymerase and Pol II CTD.
Lukarska M; Fournier G; Pflug A; Resa-Infante P; Reich S; Naffakh N; Cusack S
Nature; 2017 Jan; 541(7635):117-121. PubMed ID: 28002402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
